BD Commits $34 Million for Major Expansion in Québec
30,200 square feet of new manufacturing space expected
BD (Becton, Dickinson and Company) announced the commitment of $34 million for a major expansion of its BD Diagnostics manufacturing operation in Québec, Canada. The investment shall allow BD to transfer out of its current leased space and establish its own manufacturing facility to meet growing demand for BD's molecular diagnostic tests for the rapid detection of bacterial organisms, including those known to cause healthcare-associated infections (HAIs).
The $34 million capital investment supports acquisition of land, construction of the new facility, and purchase and maintenance of equipment. The new 64,500 square foot facility is expected to include 30,200 square feet of new manufacturing space. It is also expected to create 40 new jobs by the time construction is complete, anticipated to be May 2008, and up to 100 jobs total over the next three years.
Other news from the department manufacturing

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.